RAPID MICRO BIOSYSTEMS, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $33.6M | $28.1M | $22.5M | $17.1M | $23.2M |
| Research and development | $13.6M | $14.6M | $12.8M | $12.9M | $9.8M |
| Operating income | -$47.4M | -$49.9M | -$56.6M | -$63.2M | -$47.2M |
| Interest expense | $1.1M | $40,000 | — | — | $2.6M |
| Pretax income | -$47.1M | -$46.9M | -$52.4M | -$61.4M | -$73.4M |
| Income tax expense | $40,000 | $22,000 | $31,000 | -$576,000 | $91,000 |
| Net income | -$47.1M | -$46.9M | -$52.5M | -$60.8M | -$73.5M |
| Balance Sheet | |||||
| Cash and equivalents | $20.0M | $16.9M | $24.3M | $27.1M | $178.4M |
| Current assets | $61.2M | $80.9M | $120.4M | $138.6M | $218.1M |
| Total assets | $74.9M | $98.2M | $143.5M | $190.7M | $241.2M |
| Current liabilities | $18.5M | $17.6M | $19.0M | $19.1M | $18.2M |
| Total liabilities | $41.6M | $22.8M | $25.5M | $26.5M | $20.2M |
| Stockholders' equity | $33.2M | $75.4M | $118.0M | $164.2M | $221.0M |
| Cash Flow Statement | |||||
| Cash from operations | -$31.1M | -$44.2M | -$45.1M | -$58.5M | -$55.0M |
| Depreciation and amortization | $3.3M | $3.4M | $3.1M | $2.8M | $1.5M |
| Stock-based compensation | $4.0M | $3.9M | $4.8M | $4.0M | $1.8M |
| Capital expenditure | $850,000 | $1.4M | $1.8M | $6.7M | $3.2M |
| Free cash flow | -$31.9M | -$45.5M | -$46.9M | -$65.3M | -$58.2M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 46.2M · Free float 48.7%
Annual filing data through FY ended December 31, 2025; float as of July 13, 2026.